ArticleFrontiers in oncology2022

Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center.

Zuowei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.